CD122-Preferential
Showing 1 - 25 of 1,079
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles
Not yet recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Biospecimen Collection
- +9 more
-
Los Angeles, CaliforniaYonemoto,Lisa
Jan 13, 2023
Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)
Withdrawn
- Metastatic Melanoma
- Bempegaldesleukin (NKTR-214)
- +2 more
-
Duarte, California
- +2 more
Jun 28, 2021
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)
Active, not recruiting
- Renal Cell Carcinoma
- Metastatic Renal Cell Carcinoma
- bempegaldesleukin
- +3 more
-
Anchorage, Alaska
- +108 more
Mar 31, 2022
Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)
Completed
- Breast Cancer
- Pegylated liposomal doxorubicin
-
Tucson, Arizona
- +1 more
Jan 9, 2023
Paroxysmal Atrial Fibrillation Trial in Madrid (Vernakalant, Flecainide)
Recruiting
- Paroxysmal Atrial Fibrillation
-
Madrid, Madrid/Madrid, SpainHospital Clínico Universitario San Carlos
Aug 5, 2022
Lung Cancer ID (Identity) Study
Not yet recruiting
- Lung Cancer Stage IV
- Advanced lung cancer patients' group
-
Roma, Italy
- +1 more
Oct 4, 2023
Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)
Recruiting
- Relapsed Acute Myeloid Leukemia
- Flotetuzumab
- Donor lymphocyte infusion
-
Saint Louis, MissouriWashington University School of Medicine
Sep 7, 2022
Cataract Surgery, Glaucoma Surgery Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Ophthalmic Suspension [PRED
Withdrawn
- Cataract Surgery
- Glaucoma Surgery
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]
- (no location specified)
Nov 16, 2021
Celiac Disease, Celiac Sprue, Gluten Enteropathy Trial in Rochester (Hu-Mik- Beta-1)
Completed
- Celiac Disease
- +3 more
- Hu-Mik- Beta-1
-
Rochester, MinnesotaMayo Clinic, Rochester
Jan 16, 2020
CRACK-TARGET 1: ÉTUDE DESCRIPTIVE DE LA SENSIBILISATION
Not yet recruiting
- Cocaine Use Disorder
- Observation of behavior and search of biomarkers with 3 blood tests.3 weeks wearing an actimeter
- 3 blood tests
-
Paris, FranceHôpital Fernand Widal
Sep 15, 2023
Breast Cancer Trial (GSK3326595)
Completed
- Breast Cancer
-
London, Ontario, CanadaSt. Joseph's Health Care London
Oct 24, 2022
Leukemia, Myeloid, Acute Trial in United States (VCAR33)
Not yet recruiting
- Leukemia, Myeloid, Acute
- VCAR33
-
La Jolla, California
- +9 more
Aug 14, 2023
Ulcerative Colitis Trial in Chestnut Hill (Hydroxocobalamin with Butyrate, Placebo with Butyrate)
Not yet recruiting
- Ulcerative Colitis
- Hydroxocobalamin with Butyrate
- Placebo with Butyrate
-
Chestnut Hill, MassachusettsBrigham and Women's Hospital
Mar 4, 2022
Dual Energy Computed Tomography in Thoracic Radiotherapy
Completed
- Lung Cancer
- +2 more
- Thoracic radiotherapy
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Nov 11, 2022
Pain Perception, Secondary Hyperalgesia Trial in Basel (Study Intervention: 25 ms half-sine wave stimulation, Control
Recruiting
- Pain Perception
- Secondary Hyperalgesia
- Study Intervention: 25 ms half-sine wave stimulation
- Control Intervention: 500 µs rectangular shaped stimulation
-
Basel, SwitzerlandDepartment of Anaesthesiology, University Hospital of Basel (USB
Jun 28, 2022
Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Stereotactic body radiotherapy (SBRT)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Sep 15, 2023
HTLV-1 Trial run by the NINDS (Hu MiK-Beta-1)
Completed
- HTLV-1
- Hu MiK-Beta-1
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 26, 2019
Non-Invasive 3D Mapping for Identifying Origin and Preferential
Completed
- Premature Ventricular Complex
- Ventricular Arrythmia
- Non Invasive Electroanatomical Mapping
-
New York, New YorkLenox Hill Hospital
Apr 18, 2022
Cognitive and Motor Neurological Disorders in Short and Long
Completed
- Cognitive Disorders
- +2 more
- Test battery
-
Tours, FranceUniversity hospital
Sep 5, 2022
Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)
Not yet recruiting
- Gastric Cancer
- Small-cell Lung Cancer
- EP0057
- Olaparib tablets
-
Shanghai, Changning District, 交通大学 邮政编码, China
- +20 more
Nov 1, 2022
Function and Scar in Trigger Finger Release
Recruiting
- Trigger Finger
- Trigger Finger Release through Transverse Incision
- +2 more
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare
Jul 25, 2022
Gastric Cancer, Peritoneal Metastases, Chemo Effect Trial in London (Doxorubicin and Cisplatin)
Not yet recruiting
- Gastric Cancer
- +2 more
- Doxorubicin and Cisplatin
-
London, United KingdomImperial College London, Hammersmith Hospital Campus
Apr 1, 2022